Hong Zhu

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 08, 2025
Enfortumab vedotin plus pembrolizumab for previously untreated locally advanced or metastatic urothelial carcinoma: a cost-effectiveness analysis.

Youwen Zhu, Kun Liu, Hong Zhu

|Oct 07, 2024
TAS-102 with or without bevacizumab treatment for patients with metastatic colorectal cancer: a multi-country cost-effectiveness analysis.

Youwen Zhu, Kun Liu, Hong Zhu

|Sep 09, 2024
Chemoradiotherapy plus immunotherapy for locoregionally advanced nasopharyngeal carcinoma: A cost-effectiveness analysis.

Kun Liu, Youwen Zhu, Shan Li

|Jun 20, 2024
Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis.

Youwen Zhu, Kun Liu, Hong Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Shan Li

1 joint publications

Youwen Zhu

1 joint publications

Kun Liu